Financial Recovery Strategies keeps up to date on the latest in class action developments. Here is a recap of some of the latest key developments.
Norfolk Southern hit with class-action suit over East Palestine train derailment
A class action suit against Norfolk Southern Railway was filed in an Ohio court Thursday following a derailment earlier this month that released toxic chemicals in East Palestine, Ohio. (Read full article)
True Health New Mexico Proposes Settlement to Resolve Class Action Data Breach Lawsuit
The Albuquerque, NM-based health insurance provider, True Health New Mexico, has proposed a settlement to resolve claims related to a 2021 data breach that affected 62,983 members of its health plans. (Read full article)
Consumer Fraud PFAS Cases Continue To Rise
We previously wrote about two consumer fraud PFAS class action lawsuits filed in New York – one for a mouthwash product and the other for a sports energy drink. Now, in the last few weeks, two new lawsuits for different products types have been filed that allege similar consumer fraud allegations – one involving a popular smoothie product and the other involving a juice drink. (Read full article)
Nearly 1.3 million Illinois Facebook users are getting a second check from last year’s $650 million biometric privacy settlement
There’s another check coming this month for nearly 1.3 million Illinois Facebook users who successfully filed claims in a landmark $650 million biometric privacy settlement. A second payment of $30.61 was issued beginning Feb. 28 to everyone who cashed their initial $397 settlement check last year in the class action lawsuit. The supplemental distribution represents more than $43 million left over in the settlement fund after nearly 110,000 Illinois class members filed a claim but did not cash the first check. (Read full article)
Aetna settles proposed class-action proton beam therapy case
Aetna has agreed to pay up to $3.4 million to settle a proposed class-action lawsuit alleging it wrongly refused to cover patients’ cancer treatment, Bloomberg Law reported March 6. (Read full article)